Subthreshold nanosecond laser intervention in AMD: the LEAD study; Vessel density of superficial, intermediate and deep capillary plexuses using OCTA; Longitudinal changes in eyes with HCQ retinal toxicity
Professor Colin Green was invited to deliver a presentation at the prestigious Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Vancouver on his team’s research into diabetic retinopathy as part of their ongoing hunt for better treatments.
Macular degeneration (MD) no longer sentences patients to functional blindness, but early diagnosis and referral is crucial, as are optometrists as the front-line eye health care providers who can educate, refer and support.
Even in a good health system, children with cataracts sometimes miss out on optimal care, says Auckland University researcher Dr Lisa Hamm.
For the first time the World Glaucoma Congress (WGC) came to the Southern Hemisphere. With many of the big names in glaucoma making the trip downunder, this conference promised to be a great way of catching up with the latest thinking in glaucoma without having to cross too many time zones! It was a
Side effects and debates was the promise of this year’s Ocular Therapeutics Conference and it most certainly delivered.
The University of Auckland’s 2019 Excellence in Ophthalmology and Vision Research awards evening was planned as a special night marking 20 years since the awards began and the rise and rise of ophthalmology and vision research in New Zealand.
The Asia Pacific Academy of Ophthalmology’s 34th Congress was held in the beautiful city of Bangkok, against a backdrop of gorgeous temples juxtaposed with modern architecture mirroring this year’s APAO theme of the sciences and arts of ophthalmology.
The latest issue of Ophthalmology, the fifth edition, authored and re-edited by those doyens of ophthalmology, Drs Myron Yanoff and Jay Duker, is a beautifully written, comprehensive textbook with a clear clinical focus. In one substantial text, it covers the majority of ophthalmic conditions and pr
The following is a response from the Southern Cross Health Society to a Q&A article with Ophthalmology New Zealand (ONZ) about its work with the country’s health insurance providers and Southern Cross’ delay in funding products, such as Xen for glaucoma patients.
I really thought when I was introduced to version 1 of the Orcam wearable text-to-speech reader two years ago, I had seen the ultimate in technology for people with low or no vision. Then came version
The Australian and New Zealand Strabismus Society (ANZSS), better known as the Squint Club, held their 2019 meeting at the Melbourne Children’s Hospital.Local orthoptist Alex, kindly showed us around
